Enliven Therapeutics Inc - ELVN Income before deduction of interest, taxes and amortization

Graphic logo of enliventherapeutics.com (ELVN)

Operating profit dynamics demonstrate the current results of Enliven Therapeutics (ELVN), where 0.00 reflects the baseline level of the metric. Enliven Therapeutics targets clinics and patients with solid tumors, receiving payments through insurance. The diversification of biomarkers in drug development minimizes risks. Meanwhile, a substantial liquidity reserve ensures the stability of research cycles regardless of market volatility.

Enliven Pharma - ELVN Operating profit EBITDA (period 11/23/2025 - 11/15/2026)

Enliven Therapeutics Inc (ELVN) - metric breakdowns and financial figures

- market value and analyst target forecast:
Summary company analytics:Enliven Therapeutics
Brand item of Enliven Therapeutics, Inc.

Absolute operating profit reflects the real scale of the Enliven Therapeutics (ELVN) business, excluding the impact of accounting assumptions. This metric is calculated as the difference between operating income and expenses before depreciation and taxes. By analyzing the EBITDA trend, investors can assess the effectiveness of cost management. For this biotech firm, this indicator will become key during the commercialization of kinase inhibitors. Steady growth in this figure will confirm the company's financial stability.

Competitor analysis for Enliven Therapeutics

Genmab (GMAB) - Profit before interest, taxes and amortization|EXEL: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization NUVL (Nuvalent Corp)|KYMR (Kymera) - Operating profit before deduction of amortization|IDYA: Company profit before taxes, interest and amortization|ORIC (ORIC Corp) - Operating profit EBITDA|Operating profit EBITDA relaytx.com|Profit before payment of interest, taxes and amortization Nurix Therapeutics, Inc. (NRIX)|TYRA (Tyra Biosciences) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA VSTM (Verastem Oncology)|Operating profit before depreciation charges Monte Rosa Tx|Cullinan Oncology - Operating profit EBITDA|Profit before interest, taxes and amortization Immuneering|CCCC (C4 Therapeutics, Inc.) - Operating profit before deduction of amortization|BDTX: Company profit before taxes, interest and amortization|RPTX (reparerx.com) - Operating profit EBITDA|Profit before interest, taxes and amortization PMV Pharma PMVP|Operating profit EBITDA KPTI|Propanc Biopharma, Inc. - Operating profit before amortization|Bio Green Med Solution - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AADI|ALRN: Operating profit before deduction of amortization|blueprintmedicines.com - Company profit before taxes, interest and amortization|GLYC: Operating profit EBITDA|SpringWorks Therapeutics - Income before deduction of interest, taxes and amortization